We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
NRG Energy, Inc. (NRG) - free report >>
Badger Meter, Inc. (BMI) - free report >>
LightPath Technologies, Inc. (LPTH) - free report >>
Proto Labs, Inc. (PRLB) - free report >>
Adaptive Biotechnologies Corporation (ADPT) - free report >>
Image: Bigstock
New Strong Sell Stocks for February 1st
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Badger Meter, Inc. (BMI - Free Report) manufactures and markets flow measurement, control, and communication solutions. The Zacks Consensus Estimate for its current year earnings has been revised 3.1% downward over the last 30 days.
LightPath Technologies, Inc. (LPTH - Free Report) designs, develops, manufactures, and distributes optical components and assemblies. The Zacks Consensus Estimate for its current year earnings has been revised 14.3% downward over the last 30 days.
NRG Energy, Inc. (NRG - Free Report) is engaged in producing, selling, and delivering electricity and related products and services. The Zacks Consensus Estimate for its current year earnings has been revised 0.3% downward over the last 30 days.
Proto Labs, Inc. (PRLB - Free Report) operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts. The Zacks Consensus Estimate for its current year earnings has been revised 2.5% downward over the last 30 days.
Adaptive Biotechnologies Corporation (ADPT - Free Report) is a commercial-stage company that develops an immune medicine platform for the diagnosis and treatment of various diseases. The Zacks Consensus Estimate for its current year earnings has been revised nearly 1% downward over the last 30 days.
View the entire Zacks Rank #5 List.